semaglutide fda weight loss The has approved the first GLP-1 pill for loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular Weight Loss Drug Wegovy FDA-Approved

Research published in JAMA Network Open on GLP-1 receptor agonists and heart outcomes showed a lower risk of major heart problems, heart failure, and death from heart disease in patients using GLP-1 therapy

The table below puts the relevant compounds in context

If you're comparing your results to your husband, your male training partner, or men on Reddit stop

Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research